Can consumer wearable activity tracker-based interventions improve physical activity and cardiometabolic health in patients with chronic diseases? A systematic review and meta-analysis of randomised controlled trials.
Activity tracker
Cardiometabolic health
Chronic disease
Physical activity
Journal
The international journal of behavioral nutrition and physical activity
ISSN: 1479-5868
Titre abrégé: Int J Behav Nutr Phys Act
Pays: England
ID NLM: 101217089
Informations de publication
Date de publication:
11 05 2020
11 05 2020
Historique:
received:
19
12
2019
accepted:
06
04
2020
entrez:
13
5
2020
pubmed:
13
5
2020
medline:
3
11
2020
Statut:
epublish
Résumé
To date, it is unclear if consumer wearable activity trackers (CWATs), with or without behaviour multi-component strategies, effectively improve adherence to physical activity and health outcomes under free living conditions in populations with chronic diseases. Therefore, we systematically evaluated the efficacy of CWAT-based interventions to promote physical activity levels and cardiometabolic health in populations with chronic diseases. Randomised controlled trials were collected from five bibliographic databases (PubMed, Embase, Web of Science, The Cochrane Central Register of Controlled Trials and CINAHL). Studies were eligible for inclusion if they evaluated a CWAT-based counselling intervention versus control intervention among patients with chronic respiratory diseases, type 2 diabetes mellitus, cardiovascular diseases, overweight/obesity, cognitive disorders, or sedentary older adults. Data were pooled using a random-effects model. After deduplication 8147 were identified of which 35 studies met inclusion criteria (chronic respiratory diseases: 7, type 2 diabetes mellitus: 12, cardiovascular diseases: 6, overweight/obesity: 3, cognitive disorders: 1, sedentary older adults: 6). Compared to control groups, CWAT-based interventions significantly increased physical activity by 2123 steps per day (95% confidence interval [CI], [1605-2641]; p < 0.001). In addition, CWAT-based interventions in these populations significantly decreased systolic blood pressure (- 3.79 mm Hg; 95% CI: [- 4.53, - 3.04] mm Hg; p < 0.001), waist circumference (- 0.99 cm; 95% CI: [- 1.48, - 0.50] cm; p < 0.001) and low-density lipoprotein cholesterol concentration (- 5.70 mg/dl; 95% CI: [- 9.24, - 2.15] mg/dl; p = 0.002). CWAT-based interventions increase physical activity and have beneficial effects on important health-related outcomes such as systolic blood pressure, waist circumference and LDL cholesterol concentration in patients with chronic diseases.
Sections du résumé
BACKGROUND
To date, it is unclear if consumer wearable activity trackers (CWATs), with or without behaviour multi-component strategies, effectively improve adherence to physical activity and health outcomes under free living conditions in populations with chronic diseases. Therefore, we systematically evaluated the efficacy of CWAT-based interventions to promote physical activity levels and cardiometabolic health in populations with chronic diseases.
METHODS
Randomised controlled trials were collected from five bibliographic databases (PubMed, Embase, Web of Science, The Cochrane Central Register of Controlled Trials and CINAHL). Studies were eligible for inclusion if they evaluated a CWAT-based counselling intervention versus control intervention among patients with chronic respiratory diseases, type 2 diabetes mellitus, cardiovascular diseases, overweight/obesity, cognitive disorders, or sedentary older adults. Data were pooled using a random-effects model.
RESULTS
After deduplication 8147 were identified of which 35 studies met inclusion criteria (chronic respiratory diseases: 7, type 2 diabetes mellitus: 12, cardiovascular diseases: 6, overweight/obesity: 3, cognitive disorders: 1, sedentary older adults: 6). Compared to control groups, CWAT-based interventions significantly increased physical activity by 2123 steps per day (95% confidence interval [CI], [1605-2641]; p < 0.001). In addition, CWAT-based interventions in these populations significantly decreased systolic blood pressure (- 3.79 mm Hg; 95% CI: [- 4.53, - 3.04] mm Hg; p < 0.001), waist circumference (- 0.99 cm; 95% CI: [- 1.48, - 0.50] cm; p < 0.001) and low-density lipoprotein cholesterol concentration (- 5.70 mg/dl; 95% CI: [- 9.24, - 2.15] mg/dl; p = 0.002).
CONCLUSION
CWAT-based interventions increase physical activity and have beneficial effects on important health-related outcomes such as systolic blood pressure, waist circumference and LDL cholesterol concentration in patients with chronic diseases.
Identifiants
pubmed: 32393357
doi: 10.1186/s12966-020-00955-2
pii: 10.1186/s12966-020-00955-2
pmc: PMC7216601
doi:
Substances chimiques
Cholesterol, LDL
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
57Références
Prev Med. 2001 Aug;33(2 Pt 1):120-7
pubmed: 11493045
Int J Cardiol Heart Vessel. 2014 Sep 1;4:19-24
pubmed: 25530947
J Med Libr Assoc. 2016 Jul;104(3):240-3
pubmed: 27366130
Patient Educ Couns. 2009 May;75(2):274-8
pubmed: 19036552
Am J Cardiol. 2003 Feb 1;91(3):321-5
pubmed: 12565088
Br J Sports Med. 2019 Aug;53(16):1013-1020
pubmed: 29440040
Res Q Exerc Sport. 2007 Dec;78(5):401-6
pubmed: 18274211
J Frailty Aging. 2012;1(1):39-44
pubmed: 27092936
Respir Med. 2015 Mar;109(3):364-71
pubmed: 25682543
Respir Med. 2015 Jan;109(1):112-21
pubmed: 25499548
Diabetologia. 2016 Apr;59(4):709-18
pubmed: 26831300
Lancet. 2016 Mar 5;387(10022):957-967
pubmed: 26724178
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Diabetes Educ. 2010 Jan-Feb;36(1):132-40
pubmed: 20019197
PLoS One. 2017 Oct 11;12(10):e0186261
pubmed: 29020079
Am J Prev Med. 2012 Jan;42(1):81-8
pubmed: 22176852
Prev Med. 2009 Feb;48(2):156-63
pubmed: 19100282
J Cardiopulm Rehabil Prev. 2009 Mar-Apr;29(2):105-14
pubmed: 19305235
Eur Respir Rev. 2019 Nov 13;28(154):
pubmed: 31722891
JAMA. 2017 Jul 11;318(2):175-193
pubmed: 28697259
Exerc Sport Sci Rev. 2016 Apr;44(2):71-80
pubmed: 26829248
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Int J Telemed Appl. 2018 Sep 9;2018:7530602
pubmed: 30271433
Eur Heart J. 1996 Jun;17(6):854-63
pubmed: 8781824
Metabolism. 2008 May;57(5):605-11
pubmed: 18442621
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
J Environ Health Sci. 2016 Nov;2(6):
pubmed: 28428979
Metabolism. 2014 Apr;63(4):554-61
pubmed: 24559843
Patient Educ Couns. 2006 Apr;61(1):48-55
pubmed: 16455222
Diabet Med. 2017 May;34(5):612-620
pubmed: 28173623
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
Lancet. 2014 Mar 22;383(9922):1059-66
pubmed: 24361242
Diabetes Educ. 2006 Jan-Feb;32(1):98-107
pubmed: 16439498
JMIR Mhealth Uhealth. 2019 Apr 12;7(4):e11819
pubmed: 30977740
Int J Behav Med. 2011 Sep;18(3):188-98
pubmed: 21052886
BMC Med. 2014 Feb 27;12:36
pubmed: 24571580
BMC Med Res Methodol. 2005 Apr 20;5:13
pubmed: 15840177
Eur J Sport Sci. 2017 Apr;17(3):360-368
pubmed: 27912681
PLoS One. 2015 Nov 04;10(11):e0141274
pubmed: 26536618
Thorax. 2006 Sep;61(9):772-8
pubmed: 16738033
Lancet. 2005 Oct 8;366(9493):1267-78
pubmed: 16214597
Comput Inform Nurs. 2018 Jul;36(7):340-349
pubmed: 29742550
Diabetes Care. 2009 Aug;32(8):1404-10
pubmed: 19602539
J Sports Sci. 2018 May;36(10):1186-1193
pubmed: 28799458
Obesity (Silver Spring). 2016 Oct;24(10):2078-91
pubmed: 27670401
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
Surg Obes Relat Dis. 2015 Jan-Feb;11(1):169-77
pubmed: 25304832
Int J Obes Relat Metab Disord. 2004 Jan;28(1):113-9
pubmed: 14569279
Diabet Med. 2010 Nov;27(11):1256-63
pubmed: 20950383
Int J Behav Nutr Phys Act. 2015 Dec 18;12:159
pubmed: 26684758
Cardiovasc Diagn Ther. 2013 Jun;3(2):73-9
pubmed: 24282749
Health Educ Res. 2013 Jun;28(3):539-45
pubmed: 23492248
Metabolism. 1997 Feb;46(2):186-91
pubmed: 9030827
J Alzheimers Dis. 2016 Apr 21;53(1):161-70
pubmed: 27104905
J Appl Gerontol. 2019 Jul;38(7):1011-1022
pubmed: 29165018
Metabolism. 1994 Jul;43(7):917-24
pubmed: 8028519
Eur Respir J. 2015 Feb;45(2):347-54
pubmed: 25261324
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618787386
pubmed: 29993339
Int J Behav Nutr Phys Act. 2017 Feb 8;14(1):18
pubmed: 28178985
JAMA. 2007 Nov 21;298(19):2296-304
pubmed: 18029834
BMJ Open Diabetes Res Care. 2018 Jul 19;6(1):e000523
pubmed: 30073088
Health Educ Res. 2010 Oct;25(5):724-36
pubmed: 20338978
Ann Med. 2013 Sep;45(5-6):397-412
pubmed: 23952917
Patient Educ Couns. 2011 Dec;85(3):e237-44
pubmed: 21546203
Metabolism. 2006 Oct;55(10):1382-7
pubmed: 16979410
PLoS One. 2013 Nov 13;8(11):e80000
pubmed: 24236168
JAMA Intern Med. 2019 May 29;:
pubmed: 31141585
Patient Educ Couns. 2011 Aug;84(2):275-9
pubmed: 20732776
Int J Behav Nutr Phys Act. 2008 Sep 05;5:44
pubmed: 18775062
J Sci Med Sport. 2014 May;17(3):276-82
pubmed: 23693030
Eur Heart J. 2007 Apr;28(7):850-6
pubmed: 17403720
Prev Med. 2007 May;44(5):377-85
pubmed: 17275896
J Am Heart Assoc. 2014 Feb 26;3(1):e000702
pubmed: 24572255
Am Heart J. 2018 May;199:105-114
pubmed: 29754647
BMC Sports Sci Med Rehabil. 2015 Oct 12;7:24
pubmed: 26464801
Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72
pubmed: 26606383
Int J Cardiol. 2018 Mar 15;255:221-228
pubmed: 29425564
Am J Respir Crit Care Med. 2017 May 15;195(10):1344-1352
pubmed: 27911566
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120